Literature DB >> 28481150

Immune checkpoint inhibitors in lung cancer: an update.

Kevin Sullivan1, Isabel Preeshagul1, Daniel Budman1, Nagashree Seetharamu1.   

Abstract

Entities:  

Keywords:  PD-1; PD-L1; checkpoint inhibitors; lung cancer

Mesh：

Substances：

Year:  2017        PMID： 28481150     DOI： 10.2217/fon-2017-0044

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  2 in total

1.  Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys).

Authors:  Linlin Guo; Jay Overholser; Anthony J Good; Nicholas J Ede; Pravin T P Kaumaya
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

2.  Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.

Authors:  Yunfei Shi; Youming Lei; Li Liu; Shiyue Zhang; Wenjing Wang; Juan Zhao; Songhui Zhao; Xiaowei Dong; Ming Yao; Kai Wang; Qing Zhou
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.